Sanofi Spin-off Notes

June 3, 2022 Update

News on the EUROAPI Spin-off

  • As many supply chain problems persist in pharmaceuticals and biotech EUROAPI has an opportunity to capitalize as a new supplier
  • EUROAPI is a strong player in the active pharmaceutical ingredient (API) space with the second highest revenue
  • However, EUROAPI was spunoff from Sanofi because it was not seen as a strong enough growth opportunity by management

Sanofi Spin-off Quick Summary – March 27, 2020